WallStreetZenWallStreetZen

NASDAQ: QTRX
Quanterix Corp Stock Forecast, Predictions & Price Target

Analyst price target for QTRX

Based on 1 analyst offering 12 month price targets for Quanterix Corp.
Min Forecast
$32.00+86.59%
Avg Forecast
$32.00+86.59%
Max Forecast
$32.00+86.59%

Should I buy or sell QTRX stock?

Based on 1 analyst offering ratings for Quanterix Corp.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their QTRX stock forecasts and price targets.

QTRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-04

1 of 1

Forecast return on equity

Is QTRX forecast to generate an efficient return?
Company
N/A
Industry
20.28%
Market
28.98%

Forecast return on assets

Is QTRX forecast to generate an efficient return on assets?
Company
N/A
Industry
10.63%

QTRX revenue forecast

What is QTRX's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$141.3M+15.5%
Avg 2 year Forecast
$164.6M+34.48%
QTRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

QTRX revenue growth forecast

How is QTRX forecast to perform vs Medical Devices companies and vs the US market?
Company
15.5%
Industry
8.12%
Market
13.57%
QTRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
QTRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

QTRX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
QTRX$17.15$32.00+86.59%Buy
SIBN$15.27$25.50+66.99%Strong Buy
VREX$17.40$30.00+72.41%Buy
SILK$18.05$20.80+15.24%Buy
KIDS$30.45$37.17+22.06%Buy

Quanterix Stock Forecast FAQ

Is Quanterix Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: QTRX) stock is to Buy QTRX stock.

Out of 1 analyst, 0 (0%) are recommending QTRX as a Strong Buy, 1 (100%) are recommending QTRX as a Buy, 0 (0%) are recommending QTRX as a Hold, 0 (0%) are recommending QTRX as a Sell, and 0 (0%) are recommending QTRX as a Strong Sell.

If you're new to stock investing, here's how to buy Quanterix stock.

What is QTRX's revenue growth forecast for 2024-2025?

(NASDAQ: QTRX) Quanterix's forecast annual revenue growth rate of 15.5% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.12%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.57%.

Quanterix's revenue in 2024 is $122,368,000.On average, 2 Wall Street analysts forecast QTRX's revenue for 2024 to be $5,379,531,132, with the lowest QTRX revenue forecast at $5,366,970,138, and the highest QTRX revenue forecast at $5,392,092,126.

In 2025, QTRX is forecast to generate $6,263,748,978 in revenue, with the lowest revenue forecast at $6,253,852,437 and the highest revenue forecast at $6,273,645,519.

What is QTRX's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: QTRX) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 10.63%.

What is QTRX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year QTRX price target, the average QTRX price target is $32.00, with the highest QTRX stock price forecast at $32.00 and the lowest QTRX stock price forecast at $32.00.

The Wall Street analyst predicted that Quanterix's share price could reach $32.00 by Mar 4, 2025. The average Quanterix stock price prediction forecasts a potential upside of 86.59% from the current QTRX share price of $17.15.

What is QTRX's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: QTRX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.